Prazosin Hcl

Form: Extended-release (ER) tablets

Strength: 1 mg, 2 mg, 5 mg,10 mg

Reference Brands: Alpress LP

Category: Drugs Using Osmotic Pump Systems

Alpress LP® (prazosin HCl) is regulated in the EU and US, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP standards. In the US, FDA approval involved clinical validation and safety assessments; in the EU, CE marking certifies conformity with MDR standards. These formulations undergo validation, stability testing, and audits, with comprehensive documentation including safety profiles, clinical data, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective prazosin formulations supporting hypertension and BPH treatment worldwide, promoting optimal therapeutic outcomes and patient safety.